Semaglutide and Fatty Liver Disease: What the MASH Evidence Actually Shows
Metabolic dysfunction-associated steatohepatitis, or MASH, is a form of fatty liver disease in which excess fat in the liver is accompanied by inflammation and liver-cell injury. Over time, some people develop fibrosis, or scarring, which can progress to cirrhosis and other serious complications. Why MASH matters in a type 2 diabetes conversation MASH is closely […]